This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Anthrax Research. Top assignees: Syntaxin Limited, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Health Protection Agency. Active years: 1999-2017.
Location History:
- Salisbury, GB (1999 - 2002)
- Wiltshire, GB (2000 - 2002)
- Atlanta, GA (US) (2003)
- Abingdon, GB (2014)
- Lilburn, GA (US) (2007 - 2017)
Company Filing History:
9 out of 36 
8 out of 3,693 
7 out of 38 
Years Active: 1999-2017
Areas of Expertise:
Title: The Innovative Contributions of Conrad Padraig Quinn
Introduction: Conrad Padraig Quinn, based in Lilburn, GA, is a noted inventor with a significant portfolio of 24 patents. His work primarily focuses on advancements in the field of immunology and vaccine development, contributing to the understanding and treatment of bacterial pathogens.
Latest Patents: Among his most recent innovations are patents centered on the regulation of Bacillus anthracis lethal factor activity. One of his notable patents details the provision of antibodies capable of binding to a particular epitope that enhances the activity of lethal factor (LF) or lethal toxin (LTx), which is crucial for developing effective therapeutic interventions. Additionally, he has developed vaccines containing specific epitopes that improve acquired immunity in subjects, ultimately correlating with autoimmunity recognition.
Career Highlights: Quinn has had a fruitful career, contributing his expertise to prominent organizations such as Syntaxin Limited and the Health Protection Agency. His innovations have made significant strides in both scientific research and practical applications in health and safety.
Collaborations: Throughout his career, Quinn has collaborated with notable colleagues in the field, including Keith Foster and John Andrew Chaddock. These partnerships have fostered a collaborative environment that has propelled advancements in his research endeavors.
Conclusion: Conrad Padraig Quinn's contributions through his numerous patents demonstrate a profound dedication to innovation in immunology. His work not only enhances our understanding of bacterial pathogens but also paves the way for improved therapeutic strategies. As he continues to innovate, the impact of his research will likely resonate within the scientific community and beyond.